Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
J Pharm Sci ; 82(11): 1175-8, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8289137

RESUMEN

The pharmacokinetics of 1 g of ceftazidime administered intradermally was studied in seven healthy volunteers. The objective of the present study was to find the most appropriate mathematical model to describe the drug intake process. The concentration of ceftazidime in plasma was measured by HPLC. The disposition of the drug was described by a one-compartment pharmacokinetic model, with drug intake occurring by different processes: a zero-order process due to the administration and a first-order intake from the injection site to the systemic circulation. The Weibull model was considered as an approximation of the overall process. The mean Weibull parameters were td (time necessary to transfer 63% of the administered drug into the systemic circulation) of 2.75 +/- 0.75 h, and f (shape) of 1.04 +/- 0.15. The mean elimination half-life was 2.0 +/- 0.4 h. The area under the concentration versus time curve obtained in this study (139 +/- 46 mg.h/L) is very near to literature values reported after single intravenous doses of 1 g of ceftazidime, suggesting that the bioavailability of ceftazidime after intradermal administration may be approximately 100%. Moreover, the mean peak plasma concentration (37 +/- 16 mg/L) is in the same range as that reported in the literature after intramuscular administration of a single dose of 1 g.


Asunto(s)
Ceftazidima/farmacocinética , Administración Cutánea , Adulto , Ceftazidima/administración & dosificación , Femenino , Humanos , Masculino , Matemática , Modelos Biológicos
2.
Cah Anesthesiol ; 41(2): 163-8, 1993.
Artículo en Francés | MEDLINE | ID: mdl-8389227

RESUMEN

Reflex sympathetic dystrophy is a complex disorder consecutive to trauma, with or without proven nerve lesions, and also following diseases of the central nervous system. Sympathetic nervous system often plays the first part in the genesis of this syndrome (sympathetically-maintained pain). Recent data and theories on the pathophysiology are developed, with special attention to the recent theory of reflex sympathetic dystrophy as a disease of the alpha-adrenoceptor. Finally, the authors tried to define some means of prevention with emphasis on preemptive analgesia and regional anesthesia and analgesia techniques.


Asunto(s)
Bloqueo Nervioso Autónomo , Receptores Adrenérgicos alfa/fisiología , Distrofia Simpática Refleja/prevención & control , Distrofia Simpática Refleja/fisiopatología , Humanos , Distrofia Simpática Refleja/etiología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda